← Open Payments lookup

AVRIM FISHKIND: Open Payments

NPI 1093727943 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$231 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $333 · 2025 $231

Food & beverage: $231
CompanyPaymentsAmount
Alkermes, Inc.5$111
Neurocrine BioSciences, Inc.2$39
Teva Pharmaceuticals USA, Inc.1$20
Janssen Pharmaceuticals, Inc1$16
Luye Pharma (USA) Ltd.1$16
Axsome Therapeutics, Inc.1$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: ARISTADA, INGREZZA, UZEDY, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, Auvelity, CAPLYTA.

Industry payments across TX — which companies pay providers there.